Latest News

Pooled Cohort Equations vs PREVENT: Statin Exposure Alters ASCVD Risk Predictions / image Ming-Sum Lee, MD, PhD,  Courtesy of Kaiser Permanente Southern California
Pooled Cohort Equations vs PREVENT: Statin Exposure Alters ASCVD Risk Predictions

September 23rd 2025

The study found that although PREVENT-generated risk estimates were more consistent in a broad population, PCE estimates were more accurate in those taking statins.

Semaglutide Shows Greater CVD Risk Reduction Than Tirzepatide in Adults With Obesity: Daily Dose / image credit: ©New Africa/AdobeStock
Semaglutide Shows Greater CVD Risk Reduction Than Tirzepatide in Adults With Obesity: Daily Dose

September 23rd 2025

t Nontraditional Causes of MI Found Common in Younger Adults, Especially in Women / image courtesy of Mayo Clinic
Nontraditional Causes of MI Found Common in Younger Adults, Especially in Women

September 18th 2025

Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension / image credit  ©Sundry Photos
Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension

September 9th 2025

Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds
Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds

September 8th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.